ClinicalTrials.gg
CompletedNCT07327554XmouvUpdated Nov 18, 2026

Assessment of the Evolution of Lumbar Spine Movement Fluidity Using Xsens Inertial Sensors in Subjects With Chronic Low Back Pain Before and After Rehabilitation

An interventional study of X-sens sensor in Low Back Pain, sponsored by University Hospital, Montpellier. Completed at 1 site in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 18, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Low Back Pain by University Hospital, Montpellier — 3 open to participants now, 4 under way, 1 of them phase 3. Low Back Pain · University Hospital, Montpellier.

Started
2026
with 1 other
No phase
6 of 10
3 open now
Registered
9th of 10
by date

Among the 10 studies in Low Back Pain by University Hospital, Montpellier, this one is one of 2 that started in 2026, is one of 6 with no phase, and was the 9th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

3 of the 10 studies in Low Back Pain by University Hospital, Montpellier are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Low Back Pain by University Hospital, Montpellier, or all of them as a file.
02

Study summary

Low back pain, defined as pain located between the thoracolumbar junction and the lower gluteal fold, becomes chronic in 8% of patients. As the leading cause of disability worldwide, it has major individual and medico-economic consequences.

Three-dimensional biomechanical analysis allows exploration of movement alterations related to low back pain. Although several parameters have already been studied (maximum joint range of motion (ROM), lumbopelvic rhythm, movement variability, gait), no consistent kinematic profile has emerged. Movement fluidity, assessed by the presence of jerks (brief movement disturbances), remains under-described despite its relevance in evaluating movement quality.

Invistigators hypothesize that lumbar spine movement fluidity during flexion improves after a rehabilitation program and correlates with clinical response.

This project stands out by exploring a rarely studied parameter (movement fluidity) and integrating it as a potential indicator for rehabilitation monitoring.

03

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • Low back pain
  • kinematic
  • jerk
  • instability catch
  • aberrant movement patterns
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 65 years inclusive
  • between 18-30 kg/m²
  • Chronic low back pain lasting more than three months
  • Rehabilitation care in the Physical Medicine and Rehabilitation Department of Montpellier University Hospital

Exclusion criteria

Exclusion Criteria:

  • Sciatica episode within the last three months
  • Traumatic, tumoral, or infectious cause of low back pain
  • History of spinal, pelvic, or hip fracture
  • Inflammatory rheumatism
  • Lumbar arthrodesis
  • Severe scoliosis
  • Subject with a legal protection measure (guardianship, curatorship)
  • Subject under legal protection
  • Subject not affiliated to a social security system or not benefiting from such a system
  • Absence of informed written consent
  • Pregnant or breastfeeding women
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    Compare Movement Fluidity Before and After Rehabilitation

    Evolution of Movement Fluidity Before and After Rehabilitation in patients with chronic low back pain

    Device: X-sens sensor

Interventions

  • DeviceX-sens sensor

    kinematic movement measurement using 5 Xsens inertial sensors (Awinda) placed on the head, thoracic vertebrae (T8), lumbar vertebrae (L1, L4), and sacrum (S1), before and after the rehabilitation program (ten working days). Movement will be measured during standardized tasks including 3 lumbar spine flexions and 3 right and left lumbar rotations. Movements will be recorded by the sensors at a frequency of 100 Hz.

06

What researchers measure

Primary outcomes

  1. Correlation between the evolution of trunk flexion movement fluidity and the evolution of disability before and after rehabilitation program

    Movement velocity will be measured during flexion using Xsens inertial measurement units (head, T8, L1, L4, S1). Velocity profiles will identify acceleration and deceleration phases. Movement fluidity will be quantified by a normalized jerk metric: the count of local minima and maxima on the angular velocity curve divided by flexion/extension duration (peaks/s). This normalization accounts for variations in movement speed between individuals and measurement sessions, providing a standardized measure of movement smoothness where lower values indicate more fluid motion. Disability will be measured by the change in the score of Oswestry Disability Index (ODI) questionary between the first and last day of rehabilitation. The ODI questionary contains ten topics concerning intensity of pain and activities of daily life. Each question is scored on a scale of 0-5 where zero indicates the least amount of disability and 5 indicating most severe disability. The ODI scale range from 0 to 100

    Time frame: 2 weeks

Secondary outcomes

  1. Changes in range of motion (ROM) between the first and last day of rehabilitation program

    The evolution of trunk range of motion (degree) between the first and last day of rehabilitation will be measured during flexion and rotation movement using Xsens inertial measurement units positioned on the head and at T8, L1, L4 and S1. ROM represents the maximal angular displacement reached by the trunk during the movement and allows identification of the contribution of different segments.

    Time frame: 2 weeks

  2. Changes in maximum angular velocity between the first and last day of rehabilitation program

    The evolution of maximum angular velocity (degrees per second) between the first and last day of rehabilitation will be measured during flexion and rotation movements using Xsens inertial measurement units positioned on the head and at T8, L1, L4, S1. Angular velocity reflects the peak speed at which the trunk segment rotates during motion. The movement velocity will be assessed both locally and globally.

    Time frame: 2 weeks

  3. Changes in lumbopelvic rhythm between the first and last day of rehabilitation program

    Changes in lombopelvic rhythm between the first and last day of rehabilitation will be assessed during the flexion using Xsens inertial measurement units positioned on the head and at T8, L1, L4, S1. lombopelvic rhythm represents the coordination and relative contribution of lumbar spine and pelvic motion during bending tasks.

    Time frame: 2 weeks

  4. Changes in functional disability between the first and last day of rehabilitation program

    The evolution of functional disability between the first and last day of rehabilitation program will be measured by the Oswestry Disability Index (ODI) questionary. This self-completed questionnaire contains ten topics concerning intensity of pain, and activities of daily life. Each topic category contains 6 statements describing a growing degree of relative severity to a particular activity. The patient then checks the statement which most closely resembles their situation. Each question is scored on a scale of 0-5 where zero indicates the least amount of disability and 5 indicating most severe disability. The ODI scale range from 0 to 100 where zero corresponds

    Time frame: 2 weeks

  5. Changes in pain between the first and last day of rehabilitation program

    The evolution of pain intensity between the first and last day of rehabilitation program will be measured by Visual Analogue Scale (VAS), ranging from 0 to 10, where 0 represents no pain and 10 represents maximum pain.

    Time frame: 2 weeks

  6. Changes in psychological impact between the first and last day of rehabilitation program

    The evolution of psychological impact between the first and last day of rehabilitation program will be measured by the Hospital Anxiety and Depression Scale (HADS). The HADS consists of 7 items designed to evaluate depression and 7 for the anxiety. Each item is rated on a 4-point scale ranging, from 0 = no, not at all, to 3 = yes.

    Time frame: 2 weeks

  7. Changes in kinesiophobia between the first and last day of rehabilitation program

    The evolution of kinesiophobia between the first and last day of rehabilitation program will be measured by the Tampa Scale of Kinesiophobia (TSK) measuring the fear that pain may occur as a result of movement. The TSK is a questionnaire of 17 questions rated by a four-point ordinal scale, ranging, from 1 for strongly disagree, to 4 for strongly agree.

    Time frame: 2 weeks

  8. Changes in catastrophizing between the first and last day of rehabilitation program

    The evolution of catastrophizing between the first and last day of rehabilitation program will be measured by the Pains Catastrophizing Scale (PCS) assessing the extent of catastrophic thinking related to pain. The PCS consists of 13 items, each rated on a 5-point Likert scale (0 = not at all to 4 = all the time).

    Time frame: 2 weeks

  9. Changes in fears and beliefs regarding work and physical activity between the first and last day of rehabilitation program

    The evolution of beliefs related to fear and avoidance of pain between the first and last day of rehabilitation program will be measured by the Fear avoidance Belief Questionnaire (FABQ). The FABQ comprises 16 items. Patients are asked to rate each item on a scale ranging from 0 for 'strongly disagree' to 6 for 'strongly agree'. It consists of two sub-scores: FABQ Physical (FABQ-PA), comprising 5 items and assessing beliefs related to physical activity. FABQ Work (FABQ-W), comprising 11 items and assessing beliefs related to work.

    Time frame: 2 weeks

  10. Changes in Schober index between the first and last day of rehabilitation program

    The Schober index is a clinical assessment tool used to evaluate lumbar spine flexion and mobility. The test is performed with the subject standing upright. The examiner marks a point over the fifth lumbar vertebra (L5) and a second point 10 cm above the first. The subject is then asked to bend forward maximally, and the distance between the two marks is measured again. A normal mobility is characterized by an increase in the distance between the two markers of 4 to 7 cm.

    Time frame: 2 weeks

  11. Changes in fingertip-to-floor distance between the first and last day of rehabilitation program

    The distance between the tips of the fingers and the floor (in cm) is measured when the subject standing with knees straight, leans forward as far as possible in an attempt to touch the floor with their fingers.

    Time frame: 2 weeks

  12. Changes in heel-to-buttock distance between the first and last day of rehabilitation program

    The distance between the heel and the buttock (in cm) is measured when the subject lying in a prone position. The examiner performs passive flexion of the knee by bringing the heel closer to the buttock and measures the distance

    Time frame: 2 weeks

  13. Changes in popliteal angle between the first and last day of rehabilitation program

    The popliteal angle (in degree) is measured between the axis of the leg and the axis of the hip when the subject is lying supine and the examiner performs passive flexion of the hip to 90° followed by passive extension of the knee. The measurement is taken on both sides.

    Time frame: 2 weeks

  14. Changes in Sorensen test between the first and last day of rehabilitation program

    The Sorensen Test is a clinical assessment used to measure the isometric endurance of the trunk muscles. The subject lies prone on a table with the upper edge of the iliac crest aligned with the table edge, and the lower body secured with straps at the pelvis, knees, and ankles. With arms crossed over the chest, the subject maintains the upper body in a horizontal position unsupported. The test duration is recorded (in seconds) until the subject can no longer hold the position.

    Time frame: 2 weeks

  15. Changes in Shirado test between the first and last day of rehabilitation program

    The Shirado Test is a clinical assessment used to measure the strength and endurance of the abdominal muscles. The subject lies in a supine position with hips and knees flexed at 90 degrees, and arms crossed over the chest. The position is timed (in seconds) and the subject is asked to hold it for as long as possible. The test ends when the subject is no longer able to maintain the position.

    Time frame: 2 weeks

  16. Changes in isometric endurance of trunk muscles between the first and last day of rehabilitation program

    The isometric endurance of trunk muscles is assessed by the ratio between the time taken in the Shirado test (in seconds) and the time taken in the Sorensen test (in seconds).

    Time frame: 2 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2026 to primary completion in Jul 2026, 4 months.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's 4 months is below that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Apr 2027 → Jul 2026 and completion Apr 2027 → Jul 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 18, 2025
First posted
Jan 8, 2026
StartActual
Feb 23, 2026
Primary completionActual
Jul 10, 2026was Apr 2027
CompletionActual
Jul 10, 2026was Apr 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 18, 2026
Primary completion
Apr 2027→Jul 10, 2026 (actual)
Nov 18, 2026
Study completion
Apr 2027→Jul 10, 2026 (actual)
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Recruiting→Completed
    Primary completion Apr 2027→Jul 10, 2026 (now actual)
    Study completion Apr 2027→Jul 10, 2026 (now actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07327554
Responsible party
Sponsor
First posted
Jan 8, 2026
Start date
Feb 23, 2026
Primary completion
Jul 10, 2026
Completion
Jul 10, 2026
Last update
Nov 18, 2026

Study contacts

Isabel TAVARES, MD
principal investigator · University Hospital, Montpellier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion